FDA approves colon cancer drug combo
WASHINGTON, Jan. 23 (UPI) -- The U.S. Food and Drug Administration says it approved a new use of Avastin in combination with oxaliplatin chemotherapy for those colorectal cancer.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Eloxatin | Food and Drug Administration (FDA) | Health